Jubilant Life Sciences is seeking stakeholders’ nod to raise up to $200 million. The purpose of raising the fund is to strengthen its balance sheet by deleveraging and also to explore further growth initiatives such as expansion, acquisition, additional working capital needs and other general corporate purposes.
The company is seeking shareholders’ nod through postal ballot as it “intends to issue Indian securities and/or foreign securities for an aggregate amount not more than the rupee equivalent of $200 million with or without a green shoe option of up to 15%.
Jubilant Life Sciences is an integrated global Pharmaceutical and Life Sciences Company engaged in manufacture and supply of APIs, Solid Dosage Formulations, Specialty Pharmaceuticals and Life Science Ingredients. It also provides Services in Contract Manufacturing and Drug Discovery Solutions.
